MCRB News — Page 2
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2018-03-08 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2018-01-31 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2018-01-08 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2017-11-08 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2017-10-16 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2017-08-03 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2017-07-10 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2017-06-21 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2017-06-12 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2017-06-09 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2017-05-04 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2017-03-16 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2017-01-31 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2016-06-17 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2016-02-25 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2016-02-04 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2016-01-11 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 1.01. |
| 2015-11-10 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 2.02,5.02,9.01. |
| 2015-08-06 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2015-07-01 | Current report | SEC filing | Seres Therapeutics, Inc. filed Form 8-K | Seres Therapeutics, Inc. filed Form 8-K covering items 5.03,9.01. |